Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
1.
Arch Orthop Trauma Surg ; 140(2): 263-273, 2020 Feb.
Article in English | MEDLINE | ID: mdl-31820093

ABSTRACT

INTRODUCTION: Severe acetabular bone loss, both with or without pelvic discontinuity, remains a challenge in revision total hip arthroplasty (RTHA). The goal of our study was to evaluate the mid-term results for consecutive patients with Paprosky III acetabular bone loss with or without pelvic discontinuity who needed RTHA with custom-made acetabular implants and to compare the results to those of other studies. MATERIALS AND METHODS: Sixty-eight (68) patients with severe acetabular bone loss (Paprosky Type IIIa and IIIb), who required RTHA, were included in our study. All prostheses were constructed on the basis of thin-layer computed tomography (CT) scans of the pelvis. The visual analogue scale (VAS), Harrison hip score (HHS), and clinical and radiographic follow-up assessments were used to evaluate the outcome. RESULTS: The average follow-up time was 43 months (range 1-120 months). Implant survival at last follow-up was 75% (51 of 68). Kaplan-Meier survival analysis, with explantation as the endpoint, revealed survival rates of 82.7% (3 years) and 77% (5 years). Patients with revision of the acetabular component only had a significant higher survival rate (p 0.012). Overall revision rate was 36.7%. Reinfection rate was 34.4%. Complications included 15 (22%) periprosthetic joint infections (PJI), 7 dislocations (10.2%), and 2 aseptic loosenings (2.9%). Mean VAS at last follow-up was 1.45 compared to 3.2 preoperatively, while mean HHS improved from 21.1 points preoperatively to 61 at last follow-up. The change in both scores was thus significant (p < 0.001). CONCLUSION: Defect reconstruction with custom-made modular acetabular implants can be a good, nevertheless expensive, treatment option with clinically and radiologically satisfying results in comparison to recent studies in the literature. Nevertheless, high postoperative complication rates, especially in terms of PJI, remain a challenge.


Subject(s)
Acetabulum/surgery , Arthroplasty, Replacement, Hip , Hip Prosthesis , Reoperation , Adult , Aged , Aged, 80 and over , Arthroplasty, Replacement, Hip/adverse effects , Arthroplasty, Replacement, Hip/instrumentation , Arthroplasty, Replacement, Hip/mortality , Bone Diseases , Humans , Middle Aged , Postoperative Complications/epidemiology , Reoperation/adverse effects , Reoperation/instrumentation , Reoperation/mortality , Retrospective Studies
2.
Diagn Microbiol Infect Dis ; 93(2): 125-130, 2019 Feb.
Article in English | MEDLINE | ID: mdl-30266398

ABSTRACT

Periprosthetic joint infections (PJIs) are a major complication in total joint arthroplasty. Staphylococcus aureus and coagulase-negative staphylococci are known to cause the majority of all PJIs. This study aimed to analyze the eradication rates of S. aureus and S. epidermidis with methicillin susceptibility and methicillin resistance in a 2-stage therapy algorithm. Seventy-four patients with PJI caused by methicillin-resistant S. aureus (MRSA), methicillin-resistant coagulase-negative staphylococci (MRSE), methicillin-susceptible S. aureus (MSSA), and methicillin-susceptible coagulase-negative staphylococci (MSSE) were included, and the outcome was analyzed retrospectively. After a minimal follow-up of 2 years, n = 56 patients (75.7%) were definitively free of infection. The analysis revealed significant differences between the groups, with eradication rates as follows: MSSA (92.6%), MSSE (95.2%), MRSA (80%), and MRSE (54.2%). MRSE showed a significantly lower rate of patients graded as "definitively free of infection" as compared to patients with infections caused by MSSA, MSSE, and MRSA.


Subject(s)
Methicillin Resistance , Prosthesis-Related Infections/microbiology , Staphylococcal Infections/microbiology , Staphylococcus aureus/drug effects , Staphylococcus epidermidis/drug effects , Aged , Aged, 80 and over , Anti-Bacterial Agents/pharmacology , Anti-Bacterial Agents/therapeutic use , Female , Humans , Male , Methicillin-Resistant Staphylococcus aureus/drug effects , Middle Aged , Prosthesis-Related Infections/drug therapy , Prosthesis-Related Infections/epidemiology , Retrospective Studies , Staphylococcal Infections/drug therapy , Staphylococcal Infections/epidemiology , Treatment Outcome
3.
Infection ; 47(2): 301-305, 2019 Apr.
Article in English | MEDLINE | ID: mdl-30128751

ABSTRACT

Musculoskeletal hydatidosis is a rare but severe disease in central Europe. This case report presents the incidental finding of an osseous hydatidosis after cementless revision total hip arthroplasty in a patient without a preoperative history of hydatidosis or any clinical symptoms. Revision total hip arthroplasty had been necessary due to a septic osteonecrosis of the femoral head 2 years after osteosynthesis of a traumatic proximal femur fracture with a sliding hip screw. The positive sample was taken out of the greater trochanter in the area of the possible former entry point for the lag screw, which was macroscopic inconspicuous. Sero-analysis could afterwards confirm the suspected diagnosis. Postoperative chemotherapy with albendazole was performed for 6 months. A full-body MRI did not reveal any further cysts. This case demonstrates a possible impact of migration on the expected pathogens in revision arthroplasty. This demonstrates that in revision arthroplasty, an infection with this parasite also has to be taken into account, if the patients come from an area endemic for hydatidosis.


Subject(s)
Albendazole/therapeutic use , Anticestodal Agents/therapeutic use , Arthroplasty, Replacement, Hip , Bone Diseases/diagnosis , Echinococcosis/diagnosis , Reoperation , Adolescent , Algeria , Bone Diseases/parasitology , Bone Diseases/surgery , Echinococcosis/parasitology , Echinococcosis/surgery , Femur/injuries , Femur/parasitology , Germany , Humans , Male , Treatment Outcome
4.
Arch Orthop Trauma Surg ; 138(8): 1159-1163, 2018 Aug.
Article in English | MEDLINE | ID: mdl-29948224

ABSTRACT

INTRODUCTION: Surgical equipment, and especially the so-called 'splash basins' that are used intraoperatively, are a potential source of bacterial contamination in primary total hip arthroplasty (THA). With this risk in mind, many commercially available draping kits include plastic bags that can be used to collect fluid or to temporarily store instruments. Following this rationale, we hypothesised that first: the fluid collection bags are a potential reservoir of bacteria and second: there is a time dependency for bacterial contamination. MATERIALS AND METHODS: After ethics approval, we investigated in a prospective, internally controlled, non-blinded trial 43 patients who received primary THA. At the beginning of the surgery, we took deep, representative, intracapsular tissue samples, which served as negative controls. At the end of surgery, tissue samples were taken from the bottom of the 'fluid collection bag' for microbiological analysis. RESULTS: All 86 control samples were negative. Out of the samples taken from the bags, a pathogen could be detected in four patients (9.3%). All pathogens were detected after a surgery time lasting longer than 90 min. CONCLUSION: We were able to show that fluid collection bags are a potential reservoir for bacteria in THA when surgery time was greater than a 90-min threshold. Our data suggest that the risks from fluid collection bags outweigh the advantages of using them. Therefore, we recommend against the use of fluid collection bags intraoperatively in primary THA.


Subject(s)
Arthroplasty, Replacement, Hip/instrumentation , Equipment Contamination , Propionibacterium acnes/isolation & purification , Staphylococcus epidermidis/isolation & purification , Suction/instrumentation , Adult , Aged , Aged, 80 and over , Female , Humans , Male , Middle Aged , Operative Time , Prospective Studies
5.
Infection ; 43(1): 95-7, 2015 Feb.
Article in English | MEDLINE | ID: mdl-25037735

ABSTRACT

Acinetobacter baumannii is an emerging nosocomial pathogen primarily in countries with a high prevalence of multidrug resistance. Here we report the detection of a bla OXA23 carbapenemase-producing A. baumannii strain in a German patient with prosthetic hip joint infection following several hip joint surgeries but no history of foreign travel.


Subject(s)
Acinetobacter Infections , Acinetobacter baumannii , Hip Prosthesis/adverse effects , Prosthesis-Related Infections , Acinetobacter baumannii/drug effects , Acinetobacter baumannii/isolation & purification , Adult , Anti-Bacterial Agents/pharmacology , Anti-Bacterial Agents/therapeutic use , Drug Resistance, Multiple, Bacterial , Humans , Male , Reoperation
6.
Eur J Neurosci ; 14(2): 315-26, 2001 Jul.
Article in English | MEDLINE | ID: mdl-11553282

ABSTRACT

Acute CNS lesions lead to neuronal injury and a parallel glial activation that is accompanied by the release of neurotoxic substances. The extent of the original neuronal damage can therefore be potentiated in a process called secondary damage. As astrocytes are known to secrete immunomodulatory and neuroprotective substances, we investigated whether astrocytic factors can attenuate the amount of neuronal injury as well as the degree of microglial activation in a model of excitotoxic neurodegeneration. Treatment of organotypic hippocampal slice cultures with N-methyl-D-aspartate (NMDA) resulted in a reproducible loss of viable granule cells, partial destruction of the regular hippocampal cytoarchitecture and a concomitant accumulation of amoeboid microglial cells at sites of neuronal damage. Astrocyte-conditioned media reduced the amount of NMDA-induced neuronal injury by 45.3%, diminished the degree of microglial activation and resulted in an improved preservation of the hippocampal cytoarchitecture. Transforming growth factor (TGF)-beta failed to act as a neuroprotectant and even enhanced the amount of neuronal injury by 52.5%. Direct effects of astrocytic factors on isolated microglial cells consisted of increased microglial ramification and down-regulated expression of intercellular adhesion molecule-1, whereas incubation with TGF-beta had no such effects. In summary, our findings show that hitherto unidentified astrocyte-derived factors that are probably not identical with TGF-beta can substantially enhance neuronal survival, either by eliciting direct neuroprotective effects or by modulating the microglial response to neuronal injury.


Subject(s)
Astrocytes/metabolism , Brain Injuries/metabolism , Cell Communication/physiology , Growth Substances/metabolism , Microglia/metabolism , Nerve Degeneration/metabolism , Neurons/metabolism , Animals , Brain Injuries/pathology , Brain Injuries/physiopathology , Cell Death/drug effects , Cell Death/physiology , Cell Size/drug effects , Cell Size/physiology , Cells, Cultured/drug effects , Cells, Cultured/metabolism , Cells, Cultured/pathology , Culture Media, Conditioned/pharmacology , Dentate Gyrus/drug effects , Dentate Gyrus/metabolism , Dentate Gyrus/pathology , Disease Models, Animal , Down-Regulation/drug effects , Down-Regulation/physiology , Excitatory Amino Acid Agonists/pharmacology , Fluorescein-5-isothiocyanate/pharmacokinetics , Gliosis/metabolism , Gliosis/pathology , Gliosis/physiopathology , Hippocampus/drug effects , Hippocampus/metabolism , Hippocampus/pathology , Lectins/pharmacokinetics , Microglia/drug effects , Microglia/pathology , Microscopy, Confocal , N-Methylaspartate/pharmacology , Nerve Degeneration/chemically induced , Nerve Degeneration/physiopathology , Neurons/drug effects , Neurons/pathology , Neuroprotective Agents/pharmacology , Neurotoxins/pharmacology , Rats , Rats, Wistar , Transforming Growth Factor beta/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL